Evidence map›Paper›PMID 28224401›Full record

ArticleLa Radiologia medica2017

Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.

Alba Fiorentino, Rosario Mazzola, Stefania Naccarato, Niccolò Giaj-Levra, Sergio Fersino, Gianluisa Sicignano, Umberto Tebano, Francesco Ricchetti, Ruggero Ruggieri, Filippo Alongi

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Hypofractionated and conventionally fractionated radiotherapy for synchronous bilateral breast cancer: clinical and dosimetric outcomes.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Observational
  9. Article
  10. Article
  11. Skin and lung toxicity in synchronous bilateral breast cancer treated with volumetric-modulated arc radiotherapy: a mono-institutional experience.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alba FiorentinoRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Rosario MazzolaRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy. rosariomazzola@hotmail.it.
Stefania NaccaratoRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Niccolò Giaj-LevraRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Sergio FersinoRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Gianluisa SicignanoRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Umberto TebanoRadiation Oncology School, University of Padua, Padua, Italy.
Francesco RicchettiRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Ruggero RuggieriRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Filippo AlongiRadiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, via Don Sempreboni 5, 37034, Negrar, Verona, Italy.
Ospedale Sacro Cuore Don Calabria · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of the present retrospective analysis was to evaluate dosimetric parameters, feasibility and outcome for Synchronous Bilateral Breast Cancer (SBBC) patients treated with adjuvant radiotherapy (RT) by Volumetric Modulated Arc Therapy (VMAT).

methodsFrom September 2011 to April 2016, 1100 Breast Cancer (BC) patients were referred to our institution to receive adjuvant breast RT, and those with SBBC were selected for the present analysis. A total of 16 patients were identified. A total dose of 50 Gy in 25 fractions was prescribed to the Planning Target Volume of the whole bilateral breast (PTV

resultsWith a median follow-up of 24 months, no acute or late side effects more than grade 2 were observed. All patients are alive without any sign of disease. For target dose coverage, our observed inter-patients averages (±1 sd) were V

conclusionsThe present retrospective analysis showed the feasibility, tolerability and safety of VMAT in the treatment of SBBC patients. Further studies are necessary to confirm these preliminary data.

Indexed as

Radiotherapy, Intensity-ModulatedAdultAgedAged, 80 and overBreast NeoplasmsFeasibility StudiesFemaleHumansMiddle AgedRadiotherapy, AdjuvantRadiotherapy DosageRetrospective StudiesBilateral breast cancerBreast radiotherapyNodal irradiationSimultaneous integrated boostVMAT

Identifiers

PMID28224401
OpenAlexW2591318118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.